Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001048462-13-000048
Filing Date
2013-10-17
Accepted
2013-10-17 16:41:00
Documents
1
Group Members
CHARLES E. DAVIDSONJOSEPH M. JACOBSKAPPA INVESTORS LLCWEXFORD GP LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD CAPITAL SC13G 10-17-2013 formsc13g.htm SC 13G 237659
  Complete submission text file 0001048462-13-000048.txt   239604
Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LP (Filed by) CIK: 0001048462 (see all company filings)

EIN.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822
Business Address 200 ROUTE 31 NORTH SUITE 104 FLEMINGTON NJ 08822 (862) 703-7175
Arno Therapeutics, Inc (Subject) CIK: 0001195116 (see all company filings)

EIN.: 522286452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-83157 | Film No.: 131156912
SIC: 2834 Pharmaceutical Preparations